• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4695758)   Today's Articles (125)
For: Yersal O, Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J Clin Oncol 2014; 5(3): 412-424 [PMID: 25114856 DOI: 10.5306/wjco.v5.i3.412] [Citation(s) in RCA: 684] [Impact Index Per Article: 62.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register]  Open
Number Cited by Other Article(s)
1
Xie L, Wang Y, Wan A, Huang L, Wang Q, Tang W, Qi X, Hu X. Research trends of neoadjuvant therapy for breast cancer: A bibliometric analysis. Hum Vaccin Immunother 2025;21:2460272. [PMID: 39904891 PMCID: PMC11801352 DOI: 10.1080/21645515.2025.2460272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2024] [Revised: 01/06/2025] [Accepted: 01/25/2025] [Indexed: 02/06/2025]  Open
2
Huang R, Ye Y, Chang A, Huang H, Zheng Z, Tan L, Tang G, Luo M, Yi X, Liu P, Wu J, Luo B, Ni D. Subtyping breast lesions via collective intelligence based long-tailed recognition in ultrasound. Med Image Anal 2025;102:103548. [PMID: 40121808 DOI: 10.1016/j.media.2025.103548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Revised: 03/06/2025] [Accepted: 03/08/2025] [Indexed: 03/25/2025]
3
Guo Z, Dong RW, Wu Y, Dong S, Alahari SK. Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment. Oncogene 2025;44:1135-1152. [PMID: 40200094 DOI: 10.1038/s41388-025-03378-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Revised: 03/03/2025] [Accepted: 03/26/2025] [Indexed: 04/10/2025]
4
Bal Albayrak MG, Simsek T, Akpinar G, Kasap M, Canturk NZ. Proteomic insights into lymph node metastasis in breast cancer subtypes: Key biomarkers and pathways. Pathol Res Pract 2025;269:155938. [PMID: 40179440 DOI: 10.1016/j.prp.2025.155938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2024] [Revised: 02/27/2025] [Accepted: 03/26/2025] [Indexed: 04/05/2025]
5
Yang X, Zheng X, Liu C, Zheng J, Dong X, Ren W, Zhang T, Lou H, Fan P. Design, synthesis, and biological evaluation of novel PROTACs compounds with good ERα degradation ability. Bioorg Med Chem 2025;122:118111. [PMID: 40068483 DOI: 10.1016/j.bmc.2025.118111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2024] [Revised: 02/10/2025] [Accepted: 02/10/2025] [Indexed: 03/29/2025]
6
Edvall C, Kale N, Tani S, Ambhore S, Hossain R, Ozoude C, Van Horsen K, Mohammad J, Tuvin DM, Kalathingal S, Loganathan J, Choi Y, Sathish V, Brown J, Mallik S. Hypoxia-Responsive Polymersomes for Stemness Reduction in Patient-Derived Solid Tumor Spheroids. ACS APPLIED BIO MATERIALS 2025;8:2916-2926. [PMID: 40056142 DOI: 10.1021/acsabm.4c01735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/10/2025]
7
Sakkal M, Hajal AA. Machine learning predictions of tumor progression: How reliable are we? Comput Biol Med 2025;191:110156. [PMID: 40245687 DOI: 10.1016/j.compbiomed.2025.110156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2024] [Revised: 03/06/2025] [Accepted: 04/04/2025] [Indexed: 04/19/2025]
8
Peña R, Baulida J. Snail1 as a key prognostic biomarker of cancer-associated fibroblasts in breast tumors. Biochim Biophys Acta Rev Cancer 2025:189316. [PMID: 40222423 DOI: 10.1016/j.bbcan.2025.189316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2024] [Revised: 04/03/2025] [Accepted: 04/04/2025] [Indexed: 04/15/2025]
9
Sasi N, Preetha D, Iyyappan S, Selvamurugan N. Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression. Semin Oncol 2025;52:152340. [PMID: 40220369 DOI: 10.1016/j.seminoncol.2025.152340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2025] [Revised: 03/01/2025] [Accepted: 03/06/2025] [Indexed: 04/14/2025]
10
Larnder AH, Manges AR, Murphy RA. The estrobolome: Estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer. Int J Cancer 2025. [PMID: 40177842 DOI: 10.1002/ijc.35427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2024] [Revised: 03/18/2025] [Accepted: 03/21/2025] [Indexed: 04/05/2025]
11
Song N, Yang K, Li Y. Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female. Breast Cancer 2025:10.1007/s12282-025-01696-5. [PMID: 40178748 DOI: 10.1007/s12282-025-01696-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2024] [Accepted: 03/23/2025] [Indexed: 04/05/2025]
12
Öttl M, Steenpass J, Wilm F, Qiu J, Rübner M, Lang-Schwarz C, Taverna C, Tava F, Hartmann A, Huebner H, Beckmann MW, Fasching PA, Maier A, Erber R, Breininger K. Fully automatic HER2 tissue segmentation for interpretable HER2 scoring. J Pathol Inform 2025;17:100435. [PMID: 40236564 PMCID: PMC11999220 DOI: 10.1016/j.jpi.2025.100435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2025] [Revised: 03/03/2025] [Accepted: 03/09/2025] [Indexed: 04/17/2025]  Open
13
Sibomana O. FDA approves Datroway: a novel therapy for HR-positive, HER2-negative metastatic breast cancer. Ann Med Surg (Lond) 2025;87:2521-2522. [PMID: 40212175 PMCID: PMC11981328 DOI: 10.1097/ms9.0000000000003122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2025] [Accepted: 02/21/2025] [Indexed: 04/13/2025]  Open
14
Solaimani M, Hosseinzadeh S, Abasi M. Non-coding RNAs, a double-edged sword in breast cancer prognosis. Cancer Cell Int 2025;25:123. [PMID: 40170036 PMCID: PMC11959806 DOI: 10.1186/s12935-025-03679-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Accepted: 02/06/2025] [Indexed: 04/03/2025]  Open
15
Al-Mansour FSH, Almasoudi HH, Albarrati A. Mapping molecular landscapes in triple-negative breast cancer: insights from spatial transcriptomics. NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY 2025:10.1007/s00210-025-04057-3. [PMID: 40119898 DOI: 10.1007/s00210-025-04057-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/05/2024] [Accepted: 03/13/2025] [Indexed: 03/25/2025]
16
YOUSUF AMJAD, KHAN NAJEEBULLAH. Targeting MDM2-p53 interaction for breast cancer therapy. Oncol Res 2025;33:851-861. [PMID: 40191734 PMCID: PMC11964874 DOI: 10.32604/or.2025.058956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2024] [Accepted: 12/19/2024] [Indexed: 04/09/2025]  Open
17
Loughrey CF, Maguire S, Dłotko P, Bai L, Orr N, Jurek-Loughrey A. A novel method for subgroup discovery in precision medicine based on topological data analysis. BMC Med Inform Decis Mak 2025;25:139. [PMID: 40102808 PMCID: PMC11921513 DOI: 10.1186/s12911-025-02852-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Accepted: 01/03/2025] [Indexed: 03/20/2025]  Open
18
Doddapaneni R, Tucker JD, Lu PJ, Lu QL. Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells. Int J Mol Sci 2025;26:2661. [PMID: 40141303 PMCID: PMC11942206 DOI: 10.3390/ijms26062661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2024] [Revised: 02/18/2025] [Accepted: 03/11/2025] [Indexed: 03/28/2025]  Open
19
Cardone A, Bell D, Biurrun C, Cognetti F, Cardoso F, Piris AR, Degi C, Lux MP, Simcock R, Wassermann J, D'Antona R, Rubio IT. Awareness of genomic testing among patients with breast cancer in Europe. Breast 2025;81:104436. [PMID: 40058335 PMCID: PMC11928760 DOI: 10.1016/j.breast.2025.104436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2024] [Revised: 10/25/2024] [Accepted: 03/04/2025] [Indexed: 03/25/2025]  Open
20
McMahon AN, Reis IM, Takita C, Wright JL, Hu JJ. Metabolomic Profiling of Disease Progression Following Radiotherapy for Breast Cancer. Cancers (Basel) 2025;17:891. [PMID: 40075737 PMCID: PMC11899340 DOI: 10.3390/cancers17050891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2025] [Revised: 02/25/2025] [Accepted: 03/03/2025] [Indexed: 03/14/2025]  Open
21
Taralli S, Orlandi A, Pafundi PC, Tempesta V, Di Leone A, Pontolillo L, Scardina L, Lorusso M, Paris I, Calcagni ML. Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters. LA RADIOLOGIA MEDICA 2025;130:422-437. [PMID: 39937369 DOI: 10.1007/s11547-025-01961-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2024] [Accepted: 01/23/2025] [Indexed: 02/13/2025]
22
Luo N, Zhang K, Li X, Hu Y, Guo L. Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer. J Adv Res 2025;69:313-327. [PMID: 38615741 PMCID: PMC11954794 DOI: 10.1016/j.jare.2024.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2024] [Revised: 03/17/2024] [Accepted: 04/10/2024] [Indexed: 04/16/2024]  Open
23
Valbuena-Garcia AM, Trujillo-Cáceres SJ, Hernández Vargas JA, Diaz S, Acuña L, Perdomo S, Piñeros M. Quality of care in Colombian women with early-onset breast cancer in two time periods: findings from a nationwide administrative registry cohort. LANCET REGIONAL HEALTH. AMERICAS 2025;43:101018. [PMID: 40171140 PMCID: PMC11959378 DOI: 10.1016/j.lana.2025.101018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 10/16/2024] [Revised: 01/22/2025] [Accepted: 01/24/2025] [Indexed: 04/03/2025]
24
Consoli V, Sorrenti V, Gulisano M, Spampinato M, Vanella L. Navigating heme pathways: the breach of heme oxygenase and hemin in breast cancer. Mol Cell Biochem 2025;480:1495-1518. [PMID: 39287890 PMCID: PMC11842487 DOI: 10.1007/s11010-024-05119-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Accepted: 09/07/2024] [Indexed: 09/19/2024]
25
Saha SK, Sarkar M, Srivastava M, Dutta S, Sen S. Nuclear α-actinin-4 regulates breast cancer invasiveness and EMT. Cytoskeleton (Hoboken) 2025;82:145-157. [PMID: 39143850 DOI: 10.1002/cm.21901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Revised: 07/12/2024] [Accepted: 07/29/2024] [Indexed: 08/16/2024]
26
Cantore T, Gasperini P, Bevilacqua R, Ciani Y, Sinha S, Ruppin E, Demichelis F. PRODE recovers essential and context-essential genes through neighborhood-informed scores. Genome Biol 2025;26:42. [PMID: 40022167 PMCID: PMC11869679 DOI: 10.1186/s13059-025-03501-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Accepted: 02/05/2025] [Indexed: 03/03/2025]  Open
27
Penteado MPD, Santos ACBC, Graziano MYS, da Veiga GL, Del Giglio A, Fonseca FLA, Alves BDCA. Leukemia inhibitory factor in peripheral blood as a prognostic marker in breast cancer. Cancer Treat Res Commun 2025;43:100887. [PMID: 40023004 DOI: 10.1016/j.ctarc.2025.100887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2024] [Revised: 02/17/2025] [Accepted: 02/19/2025] [Indexed: 03/04/2025]
28
Cassali GD, Nakagaki KYR, Salvi M, dos Reys MP, Rocha MAN, de Campos CB, Ferreira E, Rodrigues ACB, dos Reis DC, Damasceno KA, Estrela-Lima A. Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer. Vet Sci 2025;12:189. [PMID: 40005948 PMCID: PMC11860833 DOI: 10.3390/vetsci12020189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2025] [Revised: 02/06/2025] [Accepted: 02/17/2025] [Indexed: 02/27/2025]  Open
29
Imanparast A, Ameri AR, Attaran N, Sharifi S, Tamayol A, Sazgarnia A, Mousavi Shaegh SA. A preclinical design approach for translation of biohybrid photosensitive nanoplatform for photodynamic therapy of breast cancer. J Control Release 2025;378:543-558. [PMID: 39701453 DOI: 10.1016/j.jconrel.2024.12.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2024] [Revised: 12/08/2024] [Accepted: 12/10/2024] [Indexed: 12/21/2024]
30
Rampogu S, Al-Antari MA, Oh TH, Shaik B. A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors. Mol Biol Rep 2025;52:203. [PMID: 39907697 DOI: 10.1007/s11033-025-10300-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2024] [Accepted: 01/23/2025] [Indexed: 02/06/2025]
31
Supplitt S, Karpinski P, Sasiadek M, Laczmanski L, Kujawa D, Matkowski R, Kasprzak P, Abrahamowska M, Maciejczyk A, Iwaneczko E, Laczmanska I. The analysis of transcriptomic signature of TNBC-searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivity. J Appl Genet 2025;66:171-182. [PMID: 38722458 PMCID: PMC11761126 DOI: 10.1007/s13353-024-00876-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2023] [Revised: 04/28/2024] [Accepted: 04/29/2024] [Indexed: 08/17/2024]
32
Dhiman P, Patil CN, Konimeni S, Meenu M. Triple-Negative, HER2/Neu, and Ki67 Markers in Breast Cancer Patients Undergoing Standard of Care Treatment in India: Real-World Evidence on Tumor Aggressiveness and Survival Outcomes. Cureus 2025;17:e78798. [PMID: 40078245 PMCID: PMC11897781 DOI: 10.7759/cureus.78798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/03/2025] [Indexed: 03/14/2025]  Open
33
Gallo M, Ferrari E, Brugnoli F, Terrazzan A, Ancona P, Volinia S, Bertagnolo V, Bergamini CM, Spisni A, Pertinhez TA, Bianchi N. Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites. Int J Mol Sci 2025;26:969. [PMID: 39940737 PMCID: PMC11816582 DOI: 10.3390/ijms26030969] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2024] [Revised: 01/22/2025] [Accepted: 01/23/2025] [Indexed: 02/16/2025]  Open
34
Molina Calistro L, Arancibia Y, Olivera MA, Domke S, Torres RF. Interaction of GPER-1 with the endocrine signaling axis in breast cancer. Front Endocrinol (Lausanne) 2025;16:1494411. [PMID: 39936103 PMCID: PMC11811623 DOI: 10.3389/fendo.2025.1494411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2024] [Accepted: 01/06/2025] [Indexed: 02/13/2025]  Open
35
Ma J, Wang H, Gui Z, Yang Y. Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy. Front Oncol 2025;14:1490073. [PMID: 39902127 PMCID: PMC11788336 DOI: 10.3389/fonc.2024.1490073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2024] [Accepted: 12/26/2024] [Indexed: 02/05/2025]  Open
36
Leng F, Huang J, Wu L, Zhang J, Lin X, Deng R, Zhu J, Li Z, Li Z, Wang Y, Zhang H, Lu D, Kipps TJ, Zhang S. Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma. iScience 2025;28:111589. [PMID: 39829682 PMCID: PMC11742321 DOI: 10.1016/j.isci.2024.111589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2024] [Revised: 10/29/2024] [Accepted: 11/13/2024] [Indexed: 01/22/2025]  Open
37
Rios-Hoyo A, Xiong K, Dai J, Yau C, Marczyk M, García-Milian R, Wolf DM, Huppert LA, Nanda R, Hirst GL, Cobain EF, van ‘t Veer LJ, Esserman LJ, Pusztai L. Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers. Clin Cancer Res 2025;31:403-413. [PMID: 39561272 PMCID: PMC11747811 DOI: 10.1158/1078-0432.ccr-24-1553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2024] [Revised: 09/16/2024] [Accepted: 11/15/2024] [Indexed: 11/21/2024]
38
Alradwan I, Zhi P, Zhang T, Lip H, Zetrini A, He C, Henderson JT, Rauth AM, Wu XY. Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer. J Control Release 2025;377:661-674. [PMID: 39615752 DOI: 10.1016/j.jconrel.2024.11.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2024] [Revised: 11/18/2024] [Accepted: 11/22/2024] [Indexed: 12/23/2024]
39
Yılmaz C, Zengel B, Üreyen O, Adıbelli ZH, Taşlı F, Yılmaz HT, Özdemir Ö, Kocatepe Çavdar D, Mollamehmetoğlu H, Çakıroğlu U, İmren Y, Yakan S, İlhan E. A Comprehensive Analysis of Neoadjuvant Chemotherapy in Breast Cancer: Adverse Events, Clinical Response Rates, and Surgical and Pathological Outcomes-Bozyaka Experience. Cancers (Basel) 2025;17:163. [PMID: 39857945 PMCID: PMC11763700 DOI: 10.3390/cancers17020163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2024] [Revised: 12/30/2024] [Accepted: 01/04/2025] [Indexed: 01/27/2025]  Open
40
Paul ED, Huraiová B, Valková N, Matyasovska N, Gábrišová D, Gubová S, Ignačáková H, Ondris T, Gala M, Barroso L, Bendíková S, Bíla J, Buranovská K, Drobná D, Krchňáková Z, Kryvokhyzha M, Lovíšek D, Mamoilyk V, Mancikova V, Vojtaššáková N, Ristová M, Comino-Méndez I, Andrašina I, Morozov P, Tuschl T, Pareja F, Kather JN, Čekan P. The spatially informed mFISHseq assay resolves biomarker discordance and predicts treatment response in breast cancer. Nat Commun 2025;16:226. [PMID: 39747865 PMCID: PMC11696812 DOI: 10.1038/s41467-024-55583-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2024] [Accepted: 12/16/2024] [Indexed: 01/04/2025]  Open
41
Verma R, Kumar K, Bhatt S, Yadav M, Kumar M, Tagde P, Rajinikanth PS, Tiwari A, Tiwari V, Nagpal D, Mittal V, Kaushik D. Untangling Breast Cancer: Trailing Towards Nanoformulations-based Drug Development. RECENT PATENTS ON NANOTECHNOLOGY 2025;19:76-98. [PMID: 37519201 DOI: 10.2174/1872210517666230731091046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/02/2023] [Revised: 06/28/2023] [Accepted: 06/28/2023] [Indexed: 08/01/2023]
42
Jang W, Lee J, Park KH, Kim A, Lee SH, Ahn S. Molecular Classification of Breast Cancer Using Weakly Supervised Learning. Cancer Res Treat 2025;57:116-125. [PMID: 38938010 PMCID: PMC11729310 DOI: 10.4143/crt.2024.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2024] [Accepted: 06/23/2024] [Indexed: 06/29/2024]  Open
43
Karouji K, Tominari T, Abe R, Sugasaki M, Ikeda K, Matsumoto C, Miyaura C, Miyata S, Nomura Y, Itoh Y, Hirata M, Inada M. Loss of ERα involved-HER2 induction mediated by the FOXO3a signaling pathway in fulvestrant-resistant breast cancer. Biochem Biophys Res Commun 2025;742:151056. [PMID: 39626368 DOI: 10.1016/j.bbrc.2024.151056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2024] [Revised: 11/16/2024] [Accepted: 11/22/2024] [Indexed: 12/21/2024]
44
Rios-Hoyo A, Shan NL, Karn PL, Pusztai L. Clinical Implications of Breast Cancer Intrinsic Subtypes. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2025;1464:435-448. [PMID: 39821037 DOI: 10.1007/978-3-031-70875-6_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2025]
45
Hermán-Sánchez N, G-García ME, Jiménez-Vacas JM, Yubero-Serrano EM, López-Sánchez LM, Romero-Martín S, Raya-Povedano JL, Álvarez-Benito M, Castaño JP, Luque RM, Gahete MD. The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer. Cell Mol Life Sci 2024;82:18. [PMID: 39725737 DOI: 10.1007/s00018-024-05515-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Revised: 10/27/2024] [Accepted: 11/15/2024] [Indexed: 12/28/2024]
46
Giffoni de Mello Morais Mata D, Pezo RC, Chan KKW, Menjak I, Eisen A, Trudeau M. A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline-Taxane Chemotherapy in Early HER-2 Negative Breast Cancer. Curr Oncol 2024;32:6. [PMID: 39851922 PMCID: PMC11764166 DOI: 10.3390/curroncol32010006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2024] [Revised: 12/17/2024] [Accepted: 12/20/2024] [Indexed: 01/30/2025]  Open
47
Bhattarai S, Sugita BM, Nunes-Souza E, Fonseca AS, Chandrashekar DS, Bhargava M, Cavalli LR, Aneja R. Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer. Int J Mol Sci 2024;25:13679. [PMID: 39769441 PMCID: PMC11679545 DOI: 10.3390/ijms252413679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2024] [Revised: 11/23/2024] [Accepted: 12/11/2024] [Indexed: 01/11/2025]  Open
48
McDonough E, Barroso M, Ginty F, Corr DT. Modeling intratumor heterogeneity in breast cancer. Biofabrication 2024;17:10.1088/1758-5090/ad9b50. [PMID: 39642392 PMCID: PMC11740194 DOI: 10.1088/1758-5090/ad9b50] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2024] [Accepted: 12/06/2024] [Indexed: 12/08/2024]
49
Acharya R, Deb PK, Venugopala KN, Pattanayak SP. An Azomethine Derivative, BCS3, Targets XIAP and cIAP1/2 to Arrest Breast Cancer Progression Through MDM2-p53 and Bcl-2-Caspase Signaling Modulation. Pharmaceuticals (Basel) 2024;17:1645. [PMID: 39770487 PMCID: PMC11678930 DOI: 10.3390/ph17121645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2024] [Revised: 11/21/2024] [Accepted: 12/02/2024] [Indexed: 01/11/2025]  Open
50
Dai R, Bao X, Liu C, Yin X, Zhu Z, Zheng Z, Wang B, Yang K, Wen H, Li W, Zhu H, Du Q, Liu J. Drug discovery of N-methyl-pyrazole derivatives as potent selective estrogen receptor degrader (SERD) for the treatment of breast cancer. Eur J Med Chem 2024;279:116894. [PMID: 39357315 DOI: 10.1016/j.ejmech.2024.116894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2024] [Revised: 09/09/2024] [Accepted: 09/17/2024] [Indexed: 10/04/2024]
PrevPage 1 of 14 123451314Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA